Skip to main content

Table 3 Cost reductions for avoided complications for the Spanish type 2 diabetes population with starting HbA1c > 48 mmol/mol

From: Improving management of glycaemic control in people with T2DM in primary care: estimation of the impact on the clinical complications and associated costs

Adult type 2 diabetes per-person cost reductions
  5 years 10 years 15 years 20 years 25 years
> 48 to ≤58 mmol/mol €198 €1754 €3653 €5221 €6027
58 to ≤64 mmol/mol €548 €2492 €4563 €6108 €6633
64 to ≤75 mmol/mol €1569 €4249 €6892 €9039 €10,233
> 75 mmol/mol €1588 €4529 €7647 €10,369 €11,966
Adult type 2 diabetes total population cost reductions
  5 years 10 years 15 years 20 years 25 years
> 48 to ≤58 mmol/mol €200,133,593 €1,772,900,617 €3,692,363,715 €5,277,260,048 €6,091,945,280
58 to ≤64 mmol/mol €160,234,152 €728,656,033 €1,334,212,472 €1,785,967,517 €1,939,476,513
64 to ≤75 mmol/mol €499,489,460 €1,352,664,574 €2,194,060,778 €2,877,555,916 €3,257,664,530
> 75 mmol/mol €458,695,151 €1,308,205,503 €2,208,842,455 €2,995,094,470 €3,456,389,279
TOTAL €1.319 bn €5.162 bn €9.429 bn €12.936 bn €14.745 bn